MISSISSAUGA, Ontario — J. Michael Pearson has been appointed to chairman of the board at Valeant Pharmaceuticals, the drug maker said Tuesday.
Pearson, who is Valeant's CEO, will extend his contract with Valeant through February 2017, the company said.
Pearson replaces current chairman Robert Ingram, who remains on the board as an independent board director and lead director.